Abstract
Methoxetamine (MXE) is a psychoactive substance distributed mostly via the Internet and is not liable to legal regulation in Poland. MXE has a toxicity profile similar to that of ketamine but longer-lasting effects. The paper describes a case of acute poisoning that resulted from recreational use of MXE and amphetamine and ended in death. In mid-July 2012, a 31-year old man was admitted to the clinical toxicology unit in Gdańsk because of poisoning with an unknown psychoactive substance. The patient was transported to the emergency department (ED) at 5:15 a.m. in a very poor general condition, in a deep coma, with acute respiratory failure, hyperthermia (> 39°C) and generalized seizures. Laboratory tests showed marked leukocytosis, signs of massive rhabdomyolysis, hepatic failure and beginning of acute renal failure. Despite intensive therapy, the patient died 4 weeks after the poisoning in the course of multi-organ dysfunction syndrome. Chemical and toxicological studies of serum and urine samples collected on the poisoning day at 1:40 p.m. confirmed that amphetamine and MXE had been taken earlier that day. Concentration of amphetamine in the serum (0.06 μg/ml) was within the non-toxic range, while MXE (0.32 μg/ml) was within the toxic range of concentrations. Amphetamine was also detected in the patient’s hair, which suggested a possibility of its use within the last dozen weeks or so. The serious clinical course of intoxication and co-existence of amphetamine and MXE in the patient’s blood and urine suggest the possibility of adverse interactions between them.
Similar content being viewed by others
References
Skowronek R, Celiński R, Chowaniec C, Skowronek A. [Ketamine and methoxetamine — old medicine and its new narcotic derivative]. Alkohol Narkom. 2012;25(3):317–326. Polish.
Hofer KE, Grager B, Müller DM, Rauber-Lüthy C, Kupferschmidt H, Rentsch KM, et al. Ketamine-like effects after recreational use of methoxetamine. Ann Emerg Med. 2012;60(1):97–99, http://dx.doi.org/10.1016/j.annemergmed.2011.11.018.
Rosenbaum CD, Carreiro SP, Babu KM. Here today, gone to-morrow… and back again? A review of herbal marijuana alternatives (K2, spice), synthetic cathinones (bath salts), kratom, salvia divinorum, methoxetamine, and piperazines. J Med Toxicol. 2012;8:15–32, http://dx.doi.org/10.1007/s13181-011-0202-2.
Kintz P, Cirimele V, Tracqui A, Mangin P. Simultaneous determination of amphetamine, methamphetamine, 3,4-methylenodioxyamphetamine and 3,4-methylenodioxymethamphetamine in human hair by gas chromatography-mass spectrometry. J Chromatogr B. 1995;670:162–166, http://dx.doi.org/10.1016/0378-4347(95)00160-K.
Roth BL, Gibbons S, Arunotayanun W, Huang Xi-Ping, Setola V, Treble R, et al. The ketamine analogue methoxetamine and 3- and 4-methoxy analogues of phencyclidine are high affinity and selective ligands for the glutamate NMDA receptor. PLoS ONE. 2013;8(3):e59334, http://dx.doi.org/10.1371/journal.pone.0059334.
Coppola M, Mondola R. Methoxetamine: From drug of abuse to rapid-acting antidepressant. Med Hypotheses. 2012;79:504–507, http://dx.doi.org/10.1016/j.mehy.2012.07.002.
Corazza O, Schifano F, Simonato P, Fergus S, Assi S, Stair J, et al. Phenomenon of new drugs on the Internet: The case of ketamine derivative methoxetamine. Hum Psychopharmacol Clin Exp. 2012;27:145–149, http://dx.doi.org/10.1002/hup.1242.
Corazza O, Assi S, Schifano F. From “Special K” to “Special M”: The evolution of the recreational use of ketamine and methoxetamine. CNS Neurosci Ther. 2013;19:454–460, http://dx.doi.org/10.1111/cns.12063.
Hill SL, Harbon SCD, Coulson J, Cooper GA, Jackson G, Lupton DJ, et al. Methoxetamine toxicity reported to the National Poisons Information Service: Clinical characteristics and patterns of enquiries (including the period of the introduction of the UK’s first Temporary Class Drug Order). Emerg Med J. 2014;31(1):45–47, http://dx.doi.org/10.1136/emermed-2012-202251.
Wood DM, Davies S, Puchnarewicz M, Johnston A, Dargan PI. Acute toxicity associated with the recreational use of the ketamine derivative methoxetamine. Eur J Clin Pharmacol. 2012,68:853–856, http://dx.doi.org/10.1007/s00228-011-1199-9.
Shields JE, Dargan PI, Wood DM, Puchnarewicz M, Davies S, Waring WS. Methoxetamine associated reversible cerebellar toxicity: Three cases with analytical confirmation. Clin Toxicol. 2012;50(5):438–440, http://dx.doi.org/10.3109/15563650.2012.683437.
Wikstrom M, Thelander G, Dahlgren M, Kronstrand R. An accidental fatal intoxication with methoxetamine. J Anal Toxicol. 2013;37:43–46, http://dx.doi.org/10.1093/jat/bks086.
Paoli GD, Brandt SD, Wallach J, Archer RP, Pounder DJ. From the street to the laboratory: Analytical profiles of methoxetamine, 3-methoxyeticyclidine and 3-methoxyphencyclidine and their determination in three biological matrices. J Anal Toxicol. 2013;37:277–283, http://dx.doi.org/10.1093/jat/bkt023.
Moffat AC, Osselton MD, Widdop B, Watts J. Clarke’s analysis of drugs and poisons. 4th ed. London: Pharmaceutical Press; 2011.
Röhrich J, Kauret G. Determination of amphetamine and methylenodioxy-amphetamine-derivatives in hair. Forensic Sci Int. 1997;84:179–188, http://dx.doi.org/10.1016/S0379-0738(96)02061-0.
Author information
Authors and Affiliations
Corresponding author
Additional information
Government-funded research (ST-33) by the Medical University of Gdańsk. Manager of the project: Zbigniew Jankowski, habilitated doctor.
About this article
Cite this article
Wiergowski, M., Anand, J.S., Krzyżanowski, M. et al. Acute methoxetamine and amphetamine poisoning with fatal outcome: A case report. IJOMEH 27, 683–690 (2014). https://doi.org/10.2478/s13382-014-0290-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.2478/s13382-014-0290-8